نتایج جستجو برای: secondary hematologic malignancy
تعداد نتایج: 360152 فیلتر نتایج به سال:
With increasing cfDNA aneuploidy screening, there is a corresponding increase in “false positive” and “non-reportable” results the setting of maternal malignancy. We hypothesize that these may be further characterized depending on stage type cancer. This was retrospective review cases with screening diagnosis malignancy during pregnancy. abstracted history, diagnoses, results, fetal outcomes fr...
BACKGROUND The clinical course for hematologic malignancy varies widely and no prognostic tool is available for patients with a hematologic malignancy under palliative care. To assess the application of the Palliative Prognostic Index (PPI), Charlson Comorbidity Index (CCI), and Glasgow Prognostic Score (GPS) as prognostic tools in patients with hematologic malignancies under palliative care. ...
Although the survival rate of hematologic malignancies in young patients is very high, cytotoxic therapies such as chemotherapy and total body irradiation therapy can significantly reduce a patient's reproductive capacity and cause irreversible infertility. Early ovarian failure also commonly occurs following additional cancer treatment, bone marrow transplantation, or autologous transplantatio...
Abnormalities of hemoglobin synthesis are usually inherited but may also arise as a secondary manifestation of another disease, most commonly hematologic neoplasia. Acquired hemoglobin disorders can be seen in any population and are not restricted to areas of the world with high incidences of inherited hemoglobinopathies. In fact, the acquired hemoglobinopathies may be more readily recognized w...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید